跳至主要内容
临床试验/JPRN-UMIN000004510
JPRN-UMIN000004510已完成4 期

Japan Home versus Office blood pressure Measurement Evaluation for Assessment of the effects of mono and combination irbesartan therapy on microaLBuminuria - J-HOME-ALB study

J-HOME-ALB study group0 个研究点目标入组 260 人开始时间: 2010年11月8日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
260

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Hypersensitivity to components of compounds of irbesartan, amlodipine, efonidipine, or trichlormethiazide 2) Past history of major cardiac events or intervention (e.g., myocardial infarction, stroke) within 6 months prior to the start of the study. 3) Secondary hypertension other than renal hypertension 4) Casual or home blood pressure >= 180 / 110 mgHG 5) Patient with severe renal disease (serum creatinine >=2.0 mg/dL), acute renal failure, hyponatremia, or hypokalemia 6) Severe hepatic disease (ALT >= 100 IU/L) 7) Cardiac failure (above NYHA grade II) 8) Cancer or poor-prognosis diseases 9) Uncontrolled diabetes mellitus (HbA1c >= 8%) 10) Pregnancy or breast feeding, or a female expecting to conceive within the study 11) Patient ineligible to this study due to other medical reasons

研究者

发起方
J-HOME-ALB study group

相似试验